BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

709 related articles for article (PubMed ID: 12535959)

  • 41. Expression of alpha1D adrenergic receptor messenger RNA in oxytocin- and corticotropin-releasing hormone-synthesizing neurons in the rat paraventricular nucleus.
    Sands SA; Morilak DA
    Neuroscience; 1999; 91(2):639-49. PubMed ID: 10366021
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Lack of decrease in hypothalamic and hippocampal glucocorticoid receptor mRNA during starvation.
    Makino S; Kaneda T; Nishiyama M; Asaba K; Hashimoto K
    Neuroendocrinology; 2001 Aug; 74(2):120-8. PubMed ID: 11474219
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Quantitative analysis of corticotropin-releasing factor and arginine vasopressin mRNA in the hypothalamus during chronic morphine treatment in rats: an in situ hybridization study.
    Laorden ML; Milanés MV; Angel E; Tankosic P; Burlet A
    J Neuroendocrinol; 2003 Jun; 15(6):586-91. PubMed ID: 12716409
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Ventral subiculum regulates hypothalamo-pituitary-adrenocortical and behavioural responses to cognitive stressors.
    Herman JP; Dolgas CM; Carlson SL
    Neuroscience; 1998 Sep; 86(2):449-59. PubMed ID: 9881860
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Increased expression of corticotropin-releasing hormone and vasopressin messenger ribonucleic acid (mRNA) in the hypothalamic paraventricular nucleus during repeated stress: association with reduction in glucocorticoid receptor mRNA levels.
    Makino S; Smith MA; Gold PW
    Endocrinology; 1995 Aug; 136(8):3299-309. PubMed ID: 7628364
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Time-dependent sensitization of corticotropin-releasing hormone, arginine vasopressin and c-fos immunoreactivity within the mouse brain in response to tumor necrosis factor-alpha.
    Hayley S; Staines W; Merali Z; Anisman H
    Neuroscience; 2001; 106(1):137-48. PubMed ID: 11564424
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Alterations in corticotropin-releasing hormone gene expression of central amygdaloid neurons following long-term paraventricular lesions and adrenalectomy.
    Palkovits M; Young WS; Kovács K; Tóth Z; Makara GB
    Neuroscience; 1998 Jul; 85(1):135-47. PubMed ID: 9607709
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Repeated administration of delta9-tetrahydrocannabinol produces a differential time related responsiveness on proenkephalin, proopiomelanocortin and corticotropin releasing factor gene expression in the hypothalamus and pituitary gland of the rat.
    Corchero J; Manzanares J; Fuentes JA
    Neuropharmacology; 1999 Mar; 38(3):433-9. PubMed ID: 10219981
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Corticotropin-releasing factor and type 1 corticotropin-releasing factor receptor messenger RNAs in rat brain and pituitary during "binge"-pattern cocaine administration and chronic withdrawal.
    Zhou Y; Spangler R; LaForge KS; Maggos CE; Ho A; Kreek MJ
    J Pharmacol Exp Ther; 1996 Oct; 279(1):351-8. PubMed ID: 8859013
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Neurotoxic lesions induced by monosodium glutamate result in increased adenopituitary proopiomelanocortin gene expression and decreased corticosterone clearance in rats.
    Skultétyová I; Kiss A; Jezová D
    Neuroendocrinology; 1998 Jun; 67(6):412-20. PubMed ID: 9662721
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effect of dexfenfluramine on the transcriptional activation of CRF and its type 1 receptor within the paraventricular nucleus of the rat hypothalamus.
    Laflamme N; Bovetto S; Richard D; Rivest S
    Br J Pharmacol; 1996 Mar; 117(6):1021-34. PubMed ID: 8882592
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Role of hypothalamic inputs in maintaining pituitary-adrenal responsiveness in repeated restraint.
    Zelena D; Mergl Z; Foldes A; Kovács KJ; Tóth Z; Makara GB
    Am J Physiol Endocrinol Metab; 2003 Nov; 285(5):E1110-7. PubMed ID: 14534078
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A single lipopolysaccharide administration is sufficient to induce a long-term desensitization of the hypothalamic-pituitary-adrenal axis.
    Vallès A; Martí O; Harbuz MS; Armario A
    Neuroscience; 2002; 112(2):383-9. PubMed ID: 12044455
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Differential neuroendocrine responses to chronic variable stress in adult Long Evans rats exposed to handling-maternal separation as neonates.
    Ladd CO; Thrivikraman KV; Huot RL; Plotsky PM
    Psychoneuroendocrinology; 2005 Jul; 30(6):520-33. PubMed ID: 15808921
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Suppression of hypothalamic-pituitary-adrenal axis responsiveness to stress in a rat model of acute cholestasis.
    Swain MG; Patchev V; Vergalla J; Chrousos G; Jones EA
    J Clin Invest; 1993 May; 91(5):1903-8. PubMed ID: 8387536
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Regulation of basal corticotropin-releasing hormone and arginine vasopressin messenger ribonucleic acid expression in the paraventricular nucleus: effects of selective hypothalamic deafferentations.
    Herman JP; Wiegand SJ; Watson SJ
    Endocrinology; 1990 Nov; 127(5):2408-17. PubMed ID: 2171915
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Stress-induced alterations in corticotropin-releasing hormone and vasopressin gene expression in the paraventricular nucleus during ontogeny.
    Dent GW; Okimoto DK; Smith MA; Levine S
    Neuroendocrinology; 2000 Jun; 71(6):333-42. PubMed ID: 10878495
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Decreased type 2 corticotropin-releasing hormone receptor mRNA expression in the ventromedial hypothalamus during repeated immobilization stress.
    Makino S; Asaba K; Nishiyama M; Hashimoto K
    Neuroendocrinology; 1999 Sep; 70(3):160-7. PubMed ID: 10516478
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Intravenous administration of interleukin-1 beta induces Fos-like immunoreactivity in corticotropin-releasing hormone neurons in the paraventricular hypothalamic nucleus of the rat.
    Veening JG; van der Meer MJ; Joosten H; Hermus AR; Rijnnkels CE; Geeraedts LM; Sweep CG
    J Chem Neuroanat; 1993; 6(6):391-7. PubMed ID: 8142074
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Evidence of lasting dysregulation of neuroendocrine and HPA axis function following global cerebral ischemia in male rats and the effect of Antalarmin on plasma corticosterone level.
    de la Tremblaye PB; Raymond J; Milot MR; Merali Z; Plamondon H
    Horm Behav; 2014 Mar; 65(3):273-84. PubMed ID: 24444675
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 36.